Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition containing theanine and astaxanthin and capable of alleviating asthenopia

A technology for relieving visual fatigue and a composition, which is applied in drug combinations, medical preparations containing active ingredients, food science, etc., can solve problems such as inattention, memory loss, and ineffective improvement of local symptoms of the eyes, etc. Broad market prospects, the effect of improving mental symptoms

Inactive Publication Date: 2018-07-31
成都图径生物科技有限公司
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the products on the market to improve visual fatigue usually only target blue light damage itself, and have no obvious improvement effect on local eye symptoms, and cannot solve other symptoms caused by different degrees of visual fatigue, such as inattention, memory loss, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition containing theanine and astaxanthin and capable of alleviating asthenopia
  • Composition containing theanine and astaxanthin and capable of alleviating asthenopia
  • Composition containing theanine and astaxanthin and capable of alleviating asthenopia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] The preparation of embodiment 1 candy product of the present invention

[0048] Raw materials in parts by weight: 6 parts of lutein esters; 2 parts of (3R, 3'R)-dihydroxy-β-carotene; 15 parts of astaxanthin (derived from Haematococcus pluvialis); 300 parts of theanine parts; 150 parts of fructo-oligosaccharides (from Jerusalem artichoke).

[0049] Preparation:

[0050] 1. Mix astaxanthin, (3R, 3'R)-dihydroxy-β-carotene, theanine, lutein ester, and fructooligosaccharides evenly according to the weight ratio, then add syrup and stir evenly.

[0051] 2. After the injection mold is cooled and formed, it can be made into hard candy, milk candy, filling candy, crisp candy, toffee, aerated candy, gelatin candy, gum base candy, tablet candy, liquid candy, film candy, Types like fancy or chocolate candies.

Embodiment 2

[0052] The preparation of embodiment 2 beverage products of the present invention

[0053] Raw materials in parts by weight: 12 parts of lutein esters; 4 parts of (3R, 3'R)-dihydroxy-β-carotene; 50 parts of anthocyanins (sourced from blueberries); 7.5 parts of astaxanthin; 100 parts of zinc (calculated as zinc); 200 parts of theanine; 150 parts of fructooligosaccharide (from Jerusalem artichoke).

[0054] Preparation:

[0055] 1. Preparation of anthocyanins: fresh blueberry fruit is ground and homogenized, extracted with ethanol, filtered, centrifuged, recovered with ethanol, adsorbed with resin, eluted with ethanol, extracted with petroleum ether, and dried to obtain blueberry extract. Calculate the amount of blueberry extract added according to the actual content of anthocyanins in the blueberry extract, and ensure that 50 parts of anthocyanins are added.

[0056] 2. Mix anthocyanin, (3R,3'R)-dihydroxy-β-carotene, astaxanthin, zinc gluconate, theanine, lutein ester, and fr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a composition containing theanine and astaxanthin and capable of alleviating asthenopia, and belongs to the field of medicines and health. The invention aims to solve the technical problem of providing the composition capable of alleviating asthenopia. The composition is a food, or a health-care product or a drug, of which the active components comprise the theanine and the astaxanthin. Crowd trial results prove that the composition not only is suitable for local symptoms of eyes having asthenopia, but also can obviously improve general symptoms such as inattention andmemory decline, caused by asthenopia in various degrees, is significant in the effect of alleviating asthenopia and has broad market prospects.

Description

technical field [0001] The invention relates to a composition containing theanine and astaxanthin for relieving visual fatigue, belonging to the field of medicine and health. Background technique [0002] Visual fatigue, also known as eye fatigue, is a syndrome based on the subjective symptoms of the patient's eyes, eye or systemic organic factors and mental (psychological) factors. It is not an independent eye disease, so it is often called eye fatigue syndrome. (Refer to: 1. Li Fengming. Chinese Ophthalmology [M]. Beijing: People's Health Publishing House, 2006, 7-8; 2. Qu Hongying et al. Research progress on etiology and treatment of visual fatigue [J]. Chinese Medicine Ophthalmology Journal, 2003, 14(1): 59-61). Mild visual fatigue will cause eye symptoms such as eye soreness and swelling after using the eyes, and will recover soon after rest; moderate visual fatigue will have obvious eye symptoms, which will affect study and work; severe visual fatigue In addition to ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A23L33/175A23L33/105A23L33/125A23L33/10A23L33/16A23G3/36A23G3/42A23G3/48A23L21/10A23L2/38A23G1/32A23G1/40A23G1/48A61K31/122A61K31/198A61P27/02
CPCA23G1/32A23G1/325A23G1/40A23G1/48A23G3/36A23G3/362A23G3/42A23G3/48A23L2/38A23L21/10A23L33/10A23L33/105A23L33/125A23L33/16A23L33/175A61K31/122A61K31/198A23V2002/00A23V2200/30A23V2200/322A23V2250/0646A23V2250/202A23V2250/2104A23V2250/211A61K2300/00
Inventor 魏巍
Owner 成都图径生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com